J. Haas, C. Kaplan, E. Gerstenberger, and K. Kerlikowske, Changes in the Use of Postmenopausal Hormone Therapy after the Publication of Clinical Trial Results, Annals of Internal Medicine, vol.140, issue.3, pp.184-188, 2004.
DOI : 10.7326/0003-4819-140-3-200402030-00009

J. Rossouw, G. Anderson, R. Prentice, A. Lacroix, C. Kooperberg et al., Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial, Jama, vol.288, pp.321-333, 2002.

W. Utian, D. Archer, G. Bachmann, C. Gallagher, F. Grodstein et al., Estrogen and progestogen use in postmenopausal women position statement of The North American Menopause Society, pp.584-602, 2008.

V. Olie, M. Canonico, and P. Scarabin, Risk of venous thrombosis with oral versus transdermal estrogen therapy among postmenopausal women, Current Opinion in Hematology, vol.17, issue.5, pp.457-463, 2010.
DOI : 10.1097/MOH.0b013e32833c07bc

P. Scarabin, E. Oger, and G. Plu-bureau, Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk, The Lancet, vol.362, issue.9382, pp.428-432, 2003.
DOI : 10.1016/S0140-6736(03)14066-4
URL : https://hal.archives-ouvertes.fr/hal-01026273

M. Canonico, E. Oger, G. Plu-bureau, J. Conard, G. Meyer et al., Hormone Therapy and Venous Thromboembolism Among Postmenopausal Women: Impact of the Route of Estrogen Administration and Progestogens: The ESTHER Study, Circulation, vol.115, issue.7, pp.840-845, 2007.
DOI : 10.1161/CIRCULATIONAHA.106.642280
URL : https://hal.archives-ouvertes.fr/hal-00688234

M. Canonico, A. Fournier, L. Carcaillon, V. Olie, G. Plu-bureau et al., Postmenopausal Hormone Therapy and Risk of Idiopathic Venous Thromboembolism: Results From the E3N Cohort Study, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.30, issue.2, pp.340-345, 2010.
DOI : 10.1161/ATVBAHA.109.196022
URL : https://hal.archives-ouvertes.fr/inserm-01142846

C. Renoux, S. Dell-'aniello, and S. Suissa, Hormone replacement therapy and the risk of venous thromboembolism: a population-based study, J Thromb Haemost, vol.8, pp.979-986, 2010.

F. Laliberte, K. Dea, S. Duh, M. Kahler, K. Rolli et al., Does the route of administration for estrogen hormone therapy impact risk of venous thromboembolism: Estradiol transdermal system vs. oral estrogen-only hormone therapy Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis Role of progestogen in hormone therapy for postmenopausal women: position statement of The North American Menopause Society, Bmj, vol.336, issue.10, pp.1227-1231113, 2003.